SEARCH

SEARCH BY CITATION

References

  • 1
    de Campos-Lima, P. O., Gavioli, R., Zhang, Q. J., Wallace, L. E., Dolcetti, R., Rowe, M., Rickinson, A. B. et al., HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 1993. 260: 98100.
  • 2
    Tan, A. T., Loggi, E., Boni, C., Chia, A., Gehring, A. J., Sastry, K. S., Goh, V. et al., Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire. J. Virol. 2008. 82: 1098610997.
  • 3
    Gaudieri, S., Rauch, A., Park, L. P., Freitas, E., Herrmann, S., Jeffrey, G., Cheng, W. et al., Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J. Virol. 2006. 80: 1109411104.
  • 4
    Moore, C. B., John, M., James, I. R., Christiansen, F. T., Witt, C. S. and Mallal, S. A., Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002. 296: 14391443.
  • 5
    Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J. et al., Phenotypic analysis of antigen-specific T lymphocytes. Science 1996. 274: 9496.
  • 6
    Davis, M. M., Altman, J. D. and Newell, E. W., Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis. Nat. Rev. Immunol. 2011. 11: 551558.
  • 7
    Wooldridge, L., Lissina, A., Cole, D. K., van den Berg, H. A., Price, D. A. and Sewell, A. K., Tricks with tetramers: how to get the most from multimeric peptide-MHC. Immunology 2009. 126: 147164.
  • 8
    Chang, C. X., Dai, L., Tan, Z. W., Choo, J. A., Bertoletti, A. and Grotenbreg, G. M., Sources of diversity in T cell epitope discovery. Front Biosci. 2011. 17: 30143035.
  • 9
    Liu, J., Zhang, S., Tan, S., Zheng, B. and Gao, G. F., Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development. Exp. Biol. Med. (Maywood) 2011. 236: 253267.
  • 10
    Hadrup, S. R., Bakker, A. H., Shu, C. J., Andersen, R. S., van Veluw, J., Hombrink, P., Castermans, E. et al., Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat. Methods 2009. 6: 520526.
  • 11
    Newell, E. W., Klein, L. O., Yu, W. and Davis, M. M., Simultaneous detection of many T-cell specificities using combinatorial tetramer staining. Nat. Methods 2009. 6: 497499.
  • 12
    Toebes, M., Coccoris, M., Bins, A., Rodenko, B., Gomez, R., Nieuwkoop, N. J., van de Kasteele, W. et al., Design and use of conditional MHC class I ligands. Nat. Med. 2006. 12: 246251.
  • 13
    Bakker, A. H., Hoppes, R., Linnemann, C., Toebes, M., Rodenko, B., Berkers, C. R., Hadrup, S. R. et al., Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc. Natl. Acad. Sci. USA 2008. 105: 38253830.
  • 14
    Grotenbreg, G. M., Roan, N. R., Guillen, E., Meijers, R., Wang, J. H., Bell, G. W., Starnbach, M. N. et al., Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramers. Proc. Natl. Acad. Sci. USA 2008. 105: 38313836.
  • 15
    Gredmark-Russ, S., Cheung, E. J., Isaacson, M. K., Ploegh, H. L. and Grotenbreg, G. M., The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens. J. Virol. 2008. 82: 1220512212.
  • 16
    Frickel, E. M., Sahoo, N., Hopp, J., Gubbels, M. J., Craver, M. P., Knoll, L. J., Ploegh, H. L. et al., Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. J. Infect. Dis. 2008. 198: 16251633.
  • 17
    Brackenridge, S., Evans, E. J., Toebes, M., Goonetilleke, N., Liu, M. K., di Gleria, K., Schumacher, T. N. et al., An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1. J. Virol. 2011. 85: 54155422.
  • 18
    Hombrink, P., Hadrup, S. R., Bakker, A., Kester, M. G., Falkenburg, J. H., von dem Borne, P. A., Schumacher, T. N. et al., High-throughput identification of potential minor histocompatibility antigens by MHC tetramer-based screening: feasibility and limitations. PLoS One 2011. 6: e22523.
  • 19
    Unger, W. W., Velthuis, J., Abreu, J. R., Laban, S., Quinten, E., Kester, M. G., Reker-Hadrup, S. et al., Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers. J. Autoimmun. 2011. 37: 151159.
  • 20
    Broen, K., Greupink-Draaisma, A., Woestenenk, R., Schaap, N., Brickner, A. G. and Dolstra, H., Concurrent detection of circulating minor histocompatibility antigen-specific CD8+ T cells in SCT recipients by combinatorial encoding MHC multimers. PLoS One 2011. 6: e21266.
  • 21
    Sidney, J., Peters, B., Frahm, N., Brander, C. and Sette, A., HLA class I supertypes: a revised and updated classification. BMC Immunol. 2008. 9: 1.
  • 22
    Hadrup, S. R., Toebes, M., Rodenko, B., Bakker, A. H., Egan, D. A., Ovaa, H. and Schumacher, T. N., High-throughput T-cell epitope discovery through MHC peptide exchange. Methods Mol. Biol. 2009. 524: 383405.
  • 23
    Chew, S. L., Or, M. Y., Chang, C. X., Gehring, A. J., Bertoletti, A. and Grotenbreg, G. M., Stability screening of arrays of major histocompatibility complexes on combinatorially encoded flow cytometry beads. J. Biol. Chem. 2011. 286: 2846628475.
  • 24
    Gehring, A. J., Xue, S. A., Ho, Z. Z., Teoh, D., Ruedl, C., Chia, A., Koh, S. et al., Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J. Hepatol. 2011. 55: 103110.
  • 25
    Oh, H. L., Chia, A., Chang, C. X., Leong, H. N., Ling, K. L., Grotenbreg, G. M., Gehring, A. J. et al., Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope. J. Virol. 2011. 85: 1046410471.
  • 26
    Lafuente, E. M. and Reche, P. A., Prediction of MHC-peptide binding: a systematic and comprehensive overview. Curr. Pharm. Des. 2009. 15: 32093220.
  • 27
    Lundegaard, C., Lund, O., Buus, S. and Nielsen, M., Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 2010. 130: 309318.
  • 28
    Hoof, I., Peters, B., Sidney, J., Pedersen, L. E., Sette, A., Lund, O., Buus, S. et al., NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 2009. 61: 113.
  • 29
    Nielsen, M., Lundegaard, C., Blicher, T., Lamberth, K., Harndahl, M., Justesen, S., Roder, G. et al., NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One 2007. 2: e796.
  • 30
    Zhang, L., Udaka, K., Mamitsuka, H. and Zhu, S., Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools. Brief Bioinform. 2011. 13: 350364.
  • 31
    Lehmann, P. V. and Zhang, W., Unique strengths of ELISPOT for T cell diagnostics. Methods Mol. Biol. 2012. 792: 323.
  • 32
    Anthony, D. D. and Lehmann, P. V., T-cell epitope mapping using the ELISPOT approach. Methods 2003. 29: 260269.
  • 33
    Bendall, S. C., Simonds, E. F., Qiu, P., Amir el, A. D., Krutzik, P. O., Finck, R., Bruggner, R. V. et al., Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011. 332: 687696.
  • 34
    Newell, E. W., Sigal, N., Bendall, S. C., Nolan, G. P. and Davis, M. M., Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8(+) T cell phenotypes. Immunity 2012. 36: 142152.
  • 35
    Rosenberg, S. A., Yang, J. C., Sherry, R. M., Kammula, U. S., Hughes, M. S., Phan, G. Q., Citrin, D. E. et al., Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy. Clin. Cancer Res. 2011. 17: 45504557.
  • 36
    Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E. et al., Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006. 314: 126129.
  • 37
    Rosenberg, S. A., Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know. Nat. Rev. Clin. Oncol. 2011. 8: 577585.
  • 38
    Butler, M. O., Friedlander, P., Milstein, M. I., Mooney, M. M., Metzler, G., Murray, A. P., Tanaka, M. et al., Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells. Sci. Transl. Med. 2011. 3: 80ra34.
  • 39
    Andersen, R. S., Kvistborg, P., Frosig, T. M., Pedersen, N. W., Lyngaa, R., Bakker, A. H., Shu, C. J. et al., Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers. Nat. Protoc. 2012. 7: 891902.
  • 40
    Andersen, M. H., Gehl, J., Reker, S., Geertsen, P., Becker, J. C. and thor Stratem, P., Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil? J. Clin. Oncol. 2005. 23: 52655267; author reply 5267–5268.